http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9106299-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b20bf4e7acb6371d23d34aa573c85847 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate | 1990-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae899c7a0cfd2818b382563c029775b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc880b8d3a46ddcf6c3c9211f42a8859 |
| publicationDate | 1991-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9106299-A1 |
| titleOfInvention | Method for the treatment of an opportunistic infection |
| abstract | There is disclosed a method for the treatment of a mammal afflicted with an opportunistic infection, which comprises administering to said mammal a therapeutically effective amount of a compound having formula (I) wherein X is CH2, O, S, or NR (R is H or alkyl), and Ar is a lipophilic aromatic group, in a pharmaceutically acceptable carrier, the amount being sufficient to substantially inhibit DHFR from the infectious organisms causing the opportunistic infection, but being insufficient to substantially inhibit mammalian DHFR. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0453556-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0453556-A1 |
| priorityDate | 1989-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.